Microbiome Modification to Enhance Stelara Response in Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This pilot study is being completed to determine whether a low-serine diet vs a high serine diet will reduce inflammation and symptoms in Crohn\'s disease (CD), as well as determine whether a low-serine diet (vs. a high serine diet) will improve responses in patients initiating therapy with Ustekinumab (Stelara), an FDA-approved biologic therapy for Crohn\'s disease.
Epistemonikos ID: b95c4dfe65e9a37e72046a4c7dda5b56f43bca12
First added on: May 08, 2024